# EDGAR Filing Document

**Accession Number:** 0001524472
**File Stem:** 0001524472-23-000004
**Filing Date:** 2023-2
**Character Count:** 59128
**Document Hash:** 1ff02b512ae95095b98b2f0a1193f3d8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001524472-23-000004.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0001524472-23-000004

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230207

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230207

**DATE AS OF CHANGE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xylem Inc.
- **CENTRAL INDEX KEY:** 0001524472
- **STANDARD INDUSTRIAL CLASSIFICATION:** PUMPS & PUMPING EQUIPMENT [3561]
- **IRS NUMBER:** 452080495
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35229
- **FILM NUMBER:** 23592749

**BUSINESS ADDRESS:**
- **STREET 1:** 301 WATER STREET SE
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20003
- **BUSINESS PHONE:** 202-869-9150

**MAIL ADDRESS:**
- **STREET 1:** 301 WATER STREET SE
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20003

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ITT WCO, Inc.
- **DATE OF NAME CHANGE:** 20110628

?xml version="1.0" ? xyl-20230207

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): February 7, 2023** 

**XYLEM INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Indiana** | **001-35229** | **45-2080495** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission<br>File Number)** | **(IRS Employer<br>Identification No.)** |

---

---

| | | |
|:---|:---|:---|
| **301 Water Street SE** | **301 Water Street SE** | **20003** |
| **Washington** | **DC** | |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**(202) 869-9150** 

**(Registrant's telephone number, including area code)**

**(Former name or former address, if changed since last report)**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange of which registered</u>** |
| Common Stock, par value $0.01 per share | XYL | New York Stock Exchange |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨

------

---

| | |
|:---|:---|
| **Item 2.02** | **Results of Operations and Financial Condition** |

---

On February 7, 2023, Xylem Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.

This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit<br> No.** | **Description** |
| <u>[99.1](xyl02072023ex991.htm)</u> | Press Release issued by Xylem Inc. on February 7, 2023. |
| 104.0 | The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL (included as Exhibit 101). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **XYLEM INC.** | **XYLEM INC.** |
| Date: February 7, 2023 | By: | /s/ Sandra E. Rowland |
|  |  | Sandra E. Rowland |
|  |  | Senior Vice President & Chief Financial Officer<br>(Authorized Officer of Registrant) |

---

## Exhibit 99.1

**Exhibit 99.1**

![xylemlogoa18a.jpg](xylemlogoa18a.jpg)

**Xylem Inc.**

301 Water Street SE, Suite 200

Washington, DC 20003

Tel +1.202.869.9150

---

| | | |
|:---|:---|:---|
| **Contacts:** | Media | Investors |
|  | Houston Spencer +1 (914) 323-5723 | Andrea van der Berg +1 (914) 260-8612 |
|  | <u>houston.spencer@xylem.com</u> | andrea.vanderberg@xylem.com |

---

**Xylem Reports Fourth Quarter and Full-Year 2022 Earnings**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Fourth quarter revenue grew 14%, up 20% organically**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Fourth quarter earnings per share of $0.82, up 32%; adjusted earnings per share of $0.92, up 46%** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Full-year revenue grew 6%, up 11% organically**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Full-year earnings per share of $1.96, down 17%; adjusted earnings per share of $2.85, up 14%** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Provides 2023 organic revenue growth guidance range of 4% to 6% and adjusted earnings per share range of $3.00 to $3.25**

**WASHINGTON D.C., February 7, 2023** – Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world's most challenging water issues, today reported fourth quarter revenue of $1.5 billion, and full-year 2022 revenue of $5.5 billion, surpassing prior guidance, with strong commercial and operational execution. While fourth quarter orders were down 9 percent on a reported basis and down 3 percent organically, the Company grew backlog 14 percent organically on resilient underlying demand. On January 23, Xylem announced it had agreed to acquire Evoqua in a $7.5 billion, all-stock transaction, creating a transformative platform to address intensifying water challenges, globally.

Fourth quarter earnings exceeded Xylem's previous guidance. Net income was $149 million, or $0.82 per share. Net income margin increased 140 basis points to 9.9 percent. These results included increased restructuring and realignment costs and higher taxes during the quarter. Adjusted net income was $168 million, or $0.92 per share, which excludes the impacts of restructuring, realignment and special charges. Fourth quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin was 18.7 percent, reflecting a year-over-year increase of 250 basis points. Strong price realization offset inflation and, coupled with productivity savings and higher volume, drove the margin expansion, exceeding the impact of strategic investments.

For the full year, net income was $355 million, or $1.96 per share. Net income margin decreased 180 basis points to 6.4 percent. These results were mainly driven by a previously announced, one-time non-cash pension plan settlement. Adjusted net income was $516 million, or $2.85 per share, which excludes the impacts of restructuring, realignment and special charges. Full-year adjusted EBITDA margin was 17.0 percent, reflecting a year-over-year decrease of 10 basis points. Inflation, strategic investments and the impact of chip shortages in the first half exceeded the benefits of price realization and productivity savings. The Company generated $596 million of operating cash flow, representing a 168 percent conversion, and $388 million of free cash flow, representing an 80 percent conversion of net income excluding the non-cash impairment charges and non-cash pension plan settlement.

------

"The team drove fourth quarter results well above expectations, with very strong performance across all business segments and regions," said Patrick Decker, Xylem president and CEO. "Resilient demand and strong backlog execution delivered robust double-digit revenue growth with significant margin expansion. That out-performance in the fourth quarter and throughout 2022 has fueled healthy momentum coming into 2023."

"Our customer focus and operational discipline are building on a foundation of resilient underlying demand for the value of Xylem's offering in our largest end-markets," continued Decker. "As trends driving water investment continue to intensify, we are confident about delivering full-year 2023 growth in the mid-single digits, with significant margin expansion, tracking solidly toward Xylem's longer-term growth milestones. Of course, we're very excited about the transformative agreement we have announced to acquire Evoqua. The combination will be positioned to have greater impact in addressing the world's water challenges and create even more value for shareholders. Until the transaction closes, however, we remain focused on delivering our commitments to our stakeholders, as we plan for a smooth integration."

Xylem announced that its Board of Directors declared a first quarter dividend in the amount of $0.33 per share, an increase of 10 percent. The dividend is payable on March 22, 2023, to shareholders of record as of February 22, 2023.

**Full-year 2023 Outlook**

Xylem's full-year and first quarter 2023 guidance does not reflect the planned acquisition of Evoqua, which was announced on January 23, 2023, and is expected to close mid-year 2023. Additional information about the proposed transaction is available at www.xylem.com/investors.

Xylem forecasts full-year 2023 revenue in the range of $5.70 to $5.80 billion, up 3 to 5 percent on a reported basis and up 4 to 6 percent on an organic basis.

Full-year 2023 adjusted EBITDA margin is expected to be in the range of 17.5 to 18.0 percent, an increase of 50 to 100 basis points. This results in adjusted earnings per share of $3.00 to $3.25, which represents an increase of 5 to 14 percent from Xylem's 2022 adjusted results. Full-year free cash flow conversion to net income is expected to be 100 percent.

Further 2023 planning assumptions are included in Xylem's fourth quarter 2022 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

**Fourth Quarter Segment Results**

**Water Infrastructure**

Xylem's Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth quarter 2022 revenue was $668 million, a 7 percent increase, 15 percent organically, compared with fourth quarter 2021. This strong growth was driven by price realization, robust utilities and industrials demand in the US and Western Europe, and dewatering demand in Emerging Markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth quarter reported operating income for the segment was $132 million, an 8 percent increase versus the comparable period last year. Adjusted operating income for the segment, which excludes $4 million of restructuring and realignment costs, was $136 million, a 10 percent

------

increase versus the comparable period last year. Reported operating margin for the segment was 19.8 percent, up 20 basis points versus the prior year, and adjusted operating margin was 20.4 percent, up 50 basis points versus the prior year. Adjusted EBITDA margin was 22.5 percent, up 80 basis points from the prior year. Favorable price realization net of inflation and higher volume more than offset strategic investments.

**Applied Water**

Xylem's Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth quarter 2022 revenue was $455 million, a 12 percent increase, 17 percent organically, year-over-year. The robust growth was driven by strong price realization across all end-markets and regions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth quarter reported operating income for the segment was $61 million, a 22 percent increase versus comparable period last year, and adjusted operating income, which excludes $9 million of restructuring and realignment costs, was $70 million, a 35 percent increase versus the comparable period last year. The segment reported operating margin was 13.4 percent, up 110 basis points versus the prior year period. Adjusted operating margin increased 260 basis points over the prior year period to 15.4 percent. Adjusted EBITDA margin was 16.5 percent, up 270 basis points from the prior year. Margin expansion was driven by strong price realization, more than offsetting inflation, coupled with productivity savings.

**Measurement & Control Solutions**

Xylem's Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth quarter 2022 revenue was $383 million, up 30 percent, 35 percent organically, versus the prior year. The robust growth is driven by improved chip supply compared to prior year, as well as strength in our water quality test and pipeline assessment applications.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth quarter reported operating income for the segment was $19 million, compared to $17 million loss in the comparable period last year, and adjusted operating income, which excludes $3 million of restructuring and realignment costs and $1 million of special charges, was $23 million, compared to $15 million loss in comparable period last year. The segment reported operating margin was 5.0 percent, up 1080 basis points versus the prior year period. Adjusted operating margin of 6.0 percent increased 1110 basis points over the prior year period. Adjusted EBITDA margin was 15.1 percent, up 800 basis points from the prior year. Strong price realization offset inflation and, coupled with productivity savings and higher volume, drove the margin expansion, exceeding the impact of strategic investments.

Supplemental information on Xylem's fourth quarter 2022 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

###

**About Xylem**

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our more than 17,000 diverse employees delivered revenue of $5.5 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize

------

water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

**Forward-Looking Statements**

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words "anticipate," "estimate," "expect," "project," "intend," "plan," "contemplate," "predict," "forecast," "likely," "believe," "target," "will," "could," "would," "should," "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by impacts from the global economic and geopolitical climate, including as a result of the war between Russia and Ukraine, the coronavirus ("COVID-19") pandemic, and macroeconomic conditions, including inflation. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine, and regulatory, economic, foreign exchange and other risks associated with our global sales, supply chain and operations, including with respect to domestic content requirements applicable to projects with governmental funding; continued uncertainty around the ongoing impacts of the COVID-19 pandemic on the macroeconomy and our business, operations, growth, and financial condition; actual or potential outbreaks of other epidemics, pandemics or global health crises; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, tight labor markets, prevailing price levels, exchange rates, tariffs and trade protection measures, energy supply, supply chain shortages, logistics challenges, and other factors; demand for our products; competition, including disruption, failure to commercialize innovative technologies, or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; availability, shortage or delays in receiving products, parts, including electronic components (in particular, semiconductors), raw materials and energy from our supply chain; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; defects, security, warranty and liability claims, and recalls with respect to products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute, consummate and integrate acquisitions; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change and related mitigation efforts by governmental or regulatory authorities; our ability to achieve our sustainability-related commitments; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; risks related to our pension and other defined benefit plans; our ability to borrow or refinance our existing indebtedness, and uncertainty around the availability of liquidity sufficient to meet our needs; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, trade, data privacy and security, our products, competition, and the environment and climate change; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; infringement or expiration of our intellectual property rights or claims that we have infringed the rights of others; and other factors set forth

------

under "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2021 ("2021 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission ("SEC").

Additionally, risks and uncertainties relating to our plans to acquire Evoqua could cause our actual results to differ, perhaps materially, from those indicated by these forward-looking statements, including: the risk that the conditions to the closing of the transaction are not satisfied, including the risk that required approvals of the transaction from the shareholders of Xylem or stockholders of Evoqua or from regulators are not obtained; litigation relating to the transaction; uncertainties as to the timing of the consummation of the transaction and the ability of each party to consummate the transaction; risks that the proposed transaction disrupts the current plans or operations of Xylem or Evoqua; the ability of Xylem and Evoqua to retain and hire key personnel; competitive responses to the proposed transaction; unexpected costs, charges or expenses resulting from the transaction; potential adverse reactions or changes to relationships with customers, suppliers, distributors and other business partners resulting from the announcement or completion of the transaction; the combined company's ability to achieve the synergies expected from the transaction, as well as delays, challenges and expenses associated with integrating the combined company's existing businesses.

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this Report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

------

**XYLEM INC. AND SUBSIDIARIES**

CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

---

| | | | |
|:---|:---|:---|:---|
| Year Ended December 31, | **2022** | 2021 | 2020 |
| Revenue | $**5522** | $5195 | $4876 |
| Cost of revenue | **3438** | 3220 | 3046 |
| &nbsp;&nbsp;&nbsp;Gross profit | **2084** | 1975 | 1830 |
| Selling, general and administrative expenses | **1227** | 1179 | 1143 |
| Research and development expenses | **206** | 204 | 187 |
| Restructuring and asset impairment charges | **29** | 7 | 75 |
| Goodwill impairment charge | **—** |  | 58 |
| &nbsp;&nbsp;&nbsp;Operating income | **622** | 585 | 367 |
| Interest expense | **50** | 76 | 77 |
| U.K. pension settlement expense | **140** |  |  |
| Other non-operating income (expense), net | **7** |  | (5) |
| Gain on sale of businesses | **1** | 2 |  |
| &nbsp;&nbsp;&nbsp;Income before taxes | **440** | 511 | 285 |
| Income tax expense | **85** | 84 | 31 |
| &nbsp;&nbsp;&nbsp;Net income | **355** | 427 | 254 |
| Earnings per share: |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $**1.97** | $2.37 | $1.41 |
| &nbsp;&nbsp;&nbsp;Diluted | $**1.96** | $2.35 | $1.40 |
| Weighted average number of shares: |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | **180.2** | 180.2 | 180.1 |
| &nbsp;&nbsp;&nbsp;Diluted | **181.0** | 181.5 | 181.1 |

---

------

**XYLEM INC. AND SUBSIDIARIES**

CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

---

| | | |
|:---|:---|:---|
| December 31, | **2022** | 2021 |
| **ASSETS** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**944** | $1349 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables, less allowances for discounts, returns and credit losses of $50 and $44 in 2022 and 2021, respectively | **1096** | 953 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **799** | 700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid and other current assets | **173** | 158 |
| Total current assets | **3012** | 3160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | **630** | 644 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | **2719** | 2792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets, net | **930** | 1016 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | **661** | 664 |
| **Total assets** | $**7952** | $8276 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $**723** | $639 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | **867** | 752 |
| Total current liabilities | **1590** | 1391 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, net | **1880** | 2440 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued post-retirement benefits | **286** | 438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | **222** | 287 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-current accrued liabilities | **471** | 494 |
| **Total liabilities** | **4449** | 5050 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock — par value $0.01 per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Authorized 750.0 shares, issued 196.0 and 195.6 shares in 2022 and 2021, respectively | **2** | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital in excess of par value | **2134** | 2089 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **2292** | 2154 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock – at cost 15.2 shares and 14.5 shares in 2021 and 2020, respectively | **(708)** | (656) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(226)** | (371) |
| **Total stockholders' equity** | **3494** | 3218 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interest | **9** | 8 |
| **Total equity** | **3503** | 3226 |
| **Total liabilities and stockholders' equity** | $**7952** | $8276 |

---

------

**XYLEM INC. AND SUBSIDIARIES**

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

---

| | | | |
|:---|:---|:---|:---|
| Year Ended December 31, | **2022** | 2021 | 2020 |
| &nbsp;&nbsp;&nbsp;**Operating Activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $**355** | $427 | $254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | **111** | 118 | 117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | **125** | 127 | 134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **(64)** | 10 | (31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **37** | 33 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset impairment charges | **29** | 7 | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment charge | **—** |  | 58 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.K. pension settlement expense | **140** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain from sale of businesses | **(1)** | (2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | **(4)** | 8 | 46 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments for restructuring | **(11)** | (25) | (36) |
| &nbsp;&nbsp;&nbsp;&nbsp;Contributions to post-retirement benefit plans | **(19)** | (29) | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities (net of acquisitions): |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in receivables | **(192)** | (70) | 109 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in inventories | **(147)** | (167) | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable | **117** | 81 | (39) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in accrued liabilities | **57** | 7 | 101 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in accrued taxes | **57** | (9) | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net changes in other assets and liabilities | **6** | 22 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash — Operating activities** | **596** | 538 | 824 |
| &nbsp;&nbsp;&nbsp;**Investing Activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Capital expenditures | **(208)** | (208) | (183) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of businesses | **1** | 10 |  |
| &nbsp;&nbsp;&nbsp;Cash received from investments | **8** | 3 | 200 |
| &nbsp;&nbsp;&nbsp;Cash paid for investments | **(11)** |  | (200) |
| &nbsp;&nbsp;&nbsp;Cash received from cross-currency swaps | **28** | 14 | 12 |
| &nbsp;&nbsp;&nbsp;Settlement of currency forward agreement | **(10)** |  |  |
| &nbsp;&nbsp;&nbsp;Other, net | **1** | (2) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash — Investing activities** | **(191)** | (183) | (169) |
| &nbsp;&nbsp;&nbsp;**Financing Activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Short-term debt issued, net | **—** |  | 359 |
| &nbsp;&nbsp;&nbsp;Short-term debt repaid, net | **—** |  | (640) |
| &nbsp;&nbsp;&nbsp;Long-term debt issued, net | **—** |  | 985 |
| &nbsp;&nbsp;&nbsp;Long-term debt repaid, net | **(527)** | (600) |  |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock | **(52)** | (68) | (61) |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise of employee stock options | **8** | 19 | 20 |
| &nbsp;&nbsp;&nbsp;Dividends paid | **(217)** | (203) | (188) |
| &nbsp;&nbsp;&nbsp;Other, net | **(2)** | (3) | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash — Financing activities** | **(790)** | (855) | 473 |
| &nbsp;&nbsp;**Effect of exchange rate changes on cash** | **(20)** | (26) | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in cash and cash equivalents | **(405)** | (526) | 1151 |
| &nbsp;&nbsp;Cash and cash equivalents at beginning of year | **1349** | 1875 | 724 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Cash and cash equivalents at end of year** | $**944** | $1349 | $1875 |
| &nbsp;&nbsp;&nbsp;**Supplemental disclosure of cash flow information:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid during the year for: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | $**76** | $99 | $77 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes (net of refunds received) | $**91** | $83 | $41 |

---

------

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

**"Organic revenue"** and **"Organic orders"** defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

**"Constant currency"** defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

**"EBITDA"** defined as earnings before interest, taxes, depreciation and amortization expense. **"Adjusted EBITDA"** and **"Adjusted Segment EBITDA"** reflects the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

**"Adjusted EBITDA Margin"** and **"Adjusted Segment EBITDA margin"** defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

**"Adjusted Operating Income"**, **"Adjusted Segment Operating Income"**, **"Adjusted Net Income"** and **"Adjusted EPS"** defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

**"Adjusted Operating Margin"** and **"Adjusted Segment Operating Margin"** defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

**"Free Cash Flow"** defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and **"Free Cash Flow Conversion"** defined as free cash flows divided by net income, excluding the gain on sale of businesses and other significant non-cash impacts, such as non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

**"Realignment costs"** defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

**"Special charges"** defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.

**"Tax-related special items"** defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

------

Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Orders

($ Millions)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **(As Reported - GAAP)** | **(As Reported - GAAP)** | **(As Reported - GAAP)** | **(As Reported - GAAP)** | **(As Adjusted - Organic)** | **(As Adjusted - Organic)** | **(As Adjusted - Organic)** | **(As Adjusted - Organic)** | **Constant Currency** |
| | | | | | | | | | (G) = (E - C) / A |
| |<br>Orders | (A)<br>Orders | (B)<br>Change 2021 v. 2020 |% Change 2021 v. 2020 | (C)<br>Acquisitions/<br>Divestitures | (D)<br>FX<br>Impact | (E)=B+C+D<br>Change<br>Adj.<br>2021 v. 2020 | (F) = E/A% Change<br>Adj. 2021 v. 2020 | |
| | 2022 | 2021 | | | | | | | |
| **<u>Year Ended December 31</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 6257 | 6300 | (43) | (1)% | 18 | 279 | 254 | 4% | 4% |
| Water Infrastructure | 2607 | 2471 | 136 | 6% |  | 166 | 302 | 12% | 12% |
| Applied Water | 1794 | 1860 | (66) | (4)% |  | 68 | 2 | 0% | 0% |
| Measurement & Control Solutions | 1856 | 1969 | (113) | (6)% | 18 | 45 | (50) | (3)% | (3)% |
| **<u>Quarter Ended December 31</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1439 | 1584 | (145) | (9)% |  | 90 | (55) | (3)% | (3)% |
| Water Infrastructure | 622 | 598 | 24 | 4% |  | 53 | 77 | 13% | 13% |
| Applied Water | 400 | 451 | (51) | (11)% |  | 23 | (28) | (6)% | (6)% |
| Measurement & Control Solutions | 417 | 535 | (118) | (22)% |  | 14 | (104) | (19)% | (19)% |
| **<u>Quarter Ended September 30</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1419 | 1518 | (99) | (7)% | 7 | 82 | (10) | (1)% | (1)% |
| Water Infrastructure | 594 | 623 | (29) | (5)% |  | 47 | 18 | 3% | 3% |
| Applied Water | 409 | 446 | (37) | (8)% |  | 20 | (17) | (4)% | (4)% |
| Measurement & Control Solutions | 416 | 449 | (33) | (7)% | 7 | 15 | (11) | (2)% | (4)% |
| **<u>Quarter Ended June 30</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1684 | 1660 | 24 | 1% | 5 | 67 | 96 | 6% | 5% |
| Water Infrastructure | 731 | 639 | 92 | 14% |  | 42 | 134 | 21% | 21% |
| Applied Water | 480 | 486 | (6) | (1)% |  | 15 | 9 | 2% | 2% |
| Measurement & Control Solutions | 473 | 535 | (62) | (12)% | 5 | 10 | (47) | (9)% | (10)% |
| **<u>Quarter Ended March 31</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1715 | 1538 | 177 | 12% | 6 | 40 | 223 | 14% | 14% |
| Water Infrastructure | 660 | 611 | 49 | 8% |  | 24 | 73 | 12% | 12% |
| Applied Water | 505 | 477 | 28 | 6% |  | 10 | 38 | 8% | 8% |
| Measurement & Control Solutions | 550 | 450 | 100 | 22% | 6 | 6 | 112 | 25% | 24% |

---

------

Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Revenue

($ Millions)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **(As Reported - GAAP)** | **(As Reported - GAAP)** | **(As Reported - GAAP)** | **(As Reported - GAAP)** | **(As Adjusted - Organic)** | **(As Adjusted - Organic)** | **(As Adjusted - Organic)** | **(As Adjusted - Organic)** | **Constant Currency** |
| | | | | | | | | | (G) = (E - C) / A |
| |<br>Revenue | (A)<br>Revenue | (B)<br>Change 2021 v. 2020 |% Change 2021 v. 2020 | (C)<br>Acquisitions/<br>Divestitures | (D)<br>FX<br>Impact | (E) = B+C+D<br>Change<br>Adj.<br>2021 v. 2020 | (F) = E/A% Change<br>Adj. 2021 v. 2020 | |
| | 2022 | 2021 | | | | | | | |
| **<u>Year Ended December 31</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 5522 | 5195 | 327 | 6% | 9 | 259 | 595 | 11% | 11% |
| Water Infrastructure | 2364 | 2247 | 117 | 5% |  | 149 | 266 | 12% | 12% |
| Applied Water | 1767 | 1613 | 154 | 10% |  | 66 | 220 | 14% | 14% |
| Measurement & Control Solutions | 1391 | 1335 | 56 | 4% | 9 | 44 | 109 | 8% | 7% |
| **<u>Quarter Ended December 31</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1506 | 1323 | 183 | 14% |  | 86 | 269 | 20% | 20% |
| Water Infrastructure | 668 | 622 | 46 | 7% |  | 50 | 96 | 15% | 15% |
| Applied Water | 455 | 406 | 49 | 12% |  | 22 | 71 | 17% | 17% |
| Measurement & Control Solutions | 383 | 295 | 88 | 30% |  | 14 | 102 | 35% | 35% |
| **<u>Quarter Ended September 30</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1380 | 1265 | 115 | 9% | 4 | 80 | 199 | 16% | 15% |
| Water Infrastructure | 574 | 547 | 27 | 5% |  | 46 | 73 | 13% | 13% |
| Applied Water | 458 | 400 | 58 | 15% |  | 21 | 79 | 20% | 20% |
| Measurement & Control Solutions | 348 | 318 | 30 | 9% | 4 | 13 | 47 | 15% | 14% |
| **<u>Quarter Ended June 30</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1364 | 1351 | 13 | 1% | 3 | 60 | 76 | 6% | 5% |
| Water Infrastructure | 589 | 569 | 20 | 4% |  | 34 | 54 | 9% | 9% |
| Applied Water | 429 | 414 | 15 | 4% |  | 15 | 30 | 7% | 7% |
| Measurement & Control Solutions | 346 | 368 | (22) | (6)% | 3 | 11 | (8) | (2)% | (3)% |
| **<u>Quarter Ended March 31</u>** |  |  |  |  |  |  |  |  |  |
| **Xylem Inc.** | 1272 | 1256 | 16 | 1% | 2 | 33 | 51 | 4% | 4% |
| Water Infrastructure | 533 | 509 | 24 | 5% |  | 19 | 43 | 8% | 8% |
| Applied Water | 425 | 393 | 32 | 8% |  | 8 | 40 | 10% | 10% |
| Measurement & Control Solutions | 314 | 354 | (40) | (11)% | 2 | 6 | (32) | (9)% | (10)% |

---

------

Xylem Inc. Non-GAAP Reconciliation

Adjusted Operating Income

($ Millions)

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q1** | **Q1** | **Q2** | **Q2** | **Q3** | **Q3** | **Q4** | **Q4** | **YTD** | **YTD** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Total Revenue |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 1272 | 1256 | 1364 | 1351 | 1380 | 1265 | 1506 | 1323 | 5522 | 5195 |
| • Water Infrastructure | 533 | 509 | 589 | 569 | 574 | 547 | 668 | 622 | 2364 | 2247 |
| • Applied Water | 425 | 393 | 429 | 414 | 458 | 400 | 455 | 406 | 1767 | 1613 |
| • Measurement & Control Solutions | 314 | 354 | 346 | 368 | 348 | 318 | 383 | 295 | 1391 | 1335 |
| Operating Income |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 111 | 133 | 146 | 160 | 168 | 152 | 197 | 140 | 622 | 585 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water Infrastructure | 74 | 71 | 108 | 93 | 104 | 101 | 132 | 122 | 418 | 387 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Applied Water | 59 | 66 | 61 | 64 | 77 | 60 | 61 | 50 | 258 | 240 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Measurement & Control Solutions | (10) | 9 | (5) | 13 | (2) | 7 | 19 | (17) | 2 | 12 |
| • Total Segments | 123 | 146 | 164 | 170 | 179 | 168 | 212 | 155 | 678 | 639 |
| Operating Margin |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 8.7% | 10.6% | 10.7% | 11.8% | 12.2% | 12.0% | 13.1% | 10.6% | 11.3% | 11.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water Infrastructure | 13.9% | 13.9% | 18.3% | 16.3% | 18.1% | 18.5% | 19.8% | 19.6% | 17.7% | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Applied Water | 13.9% | 16.8% | 14.2% | 15.5% | 16.8% | 15.0% | 13.4% | 12.3% | 14.6% | 14.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Measurement & Control Solutions | (3.2)% | 2.5% | (1.4)% | 3.5% | (0.6)% | 2.2% | 5.0% | (5.8)% | 0.1% | 0.9% |
| • Total Segments | 9.7% | 11.6% | 12.0% | 12.6% | 13.0% | 13.3% | 14.1% | 11.7% | 12.3% | 12.3% |
| Special Charges |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 1 | 2 | 1 |  | 13 | 1 | 1 | 1 | 16 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water Infrastructure |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Applied Water |  | 1 |  |  |  |  |  |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Measurement & Control Solutions |  |  | 1 |  | 12 |  | 1 |  | 14 |  |
| • Total Segments |  | 1 | 1 |  | 12 |  | 1 |  | 14 | 1 |
| Restructuring & Realignment Costs |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 4 | 8 | 8 | 6 | 6 | 2 | 16 | 6 | 34 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water Infrastructure | 1 | 5 | 3 | 4 | 3 | 1 | 4 | 2 | 11 | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Applied Water | 1 | 1 | 2 | 2 | 1 | 2 | 9 | 2 | 13 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Measurement & Control Solutions | 2 | 2 | 3 |  | 2 | (1) | 3 | 2 | 10 | 3 |
| • Total Segments | 4 | 8 | 8 | 6 | 6 | 2 | 16 | 6 | 34 | 22 |
| Adjusted Operating Income |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 116 | 143 | 155 | 166 | 187 | 155 | 214 | 147 | 672 | 611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water Infrastructure | 75 | 76 | 111 | 97 | 107 | 102 | 136 | 124 | 429 | 399 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Applied Water | 60 | 68 | 63 | 66 | 78 | 62 | 70 | 52 | 271 | 248 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Measurement & Control Solutions | (8) | 11 | (1) | 13 | 12 | 6 | 23 | (15) | 26 | 15 |
| • Total Segments | 127 | 155 | 173 | 176 | 197 | 170 | 229 | 161 | 726 | 662 |
| Adjusted Operating Margin |  |  |  |  |  |  |  |  |  |  |
| • Total Xylem | 9.1% | 11.4% | 11.4% | 12.3% | 13.6% | 12.3% | 14.2% | 11.1% | 12.2% | 11.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water Infrastructure | 14.1% | 14.9% | 18.8% | 17.0% | 18.6% | 18.6% | 20.4% | 19.9% | 18.1% | 17.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Applied Water | 14.1% | 17.3% | 14.7% | 15.9% | 17.0% | 15.5% | 15.4% | 12.8% | 15.3% | 15.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Measurement & Control Solutions | (2.5)% | 3.1% | (0.3)% | 3.5% | 3.4% | 1.9% | 6.0% | (5.1)% | 1.9% | 1.1% |
| • Total Segments | 10.0% | 12.3% | 12.7% | 13.0% | 14.3% | 13.4% | 15.2% | 12.2% | 13.1% | 12.7% |

---

------

Xylem Inc. Non-GAAP Reconciliation

Adjusted Diluted EPS

($ Millions, except per share amounts)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 2022** | **Q4 2022** | **Q4 2022** | **Q4 2022** | **Q4 2021** | **Q4 2021** | **Q4 2021** | **Q4 2021** |
| | As Reported | Adjustments | | Adjusted | As Reported | Adjustments | | Adjusted |
| Total Revenue | 1506 |  |  | 1506 | 1323 |  |  | 1323 |
| Operating Income | 197 | 17 | a | 214 | 140 | 7 | a | 147 |
| Operating Margin | *13.1 %* |  |  | *14.2 %* | *10.6 %* |  |  | *11.1 %* |
| Interest Expense | (13) |  |  | (13) | (13) |  |  | (13) |
| Other Non-Operating Income (Expense) | 5 |  |  | 5 | (1) | 3 | b | 2 |
| Income before Taxes | 189 |  |  | 206 | 126 | 10 |  | 136 |
| Provision for Income Taxes | (40) | 2 | c | (38) | (13) | (8) | c | (21) |
| Net Income attributable to Xylem | 149 | 2 |  | 168 | 113 | 2 |  | 115 |
| Diluted Shares | 181.3 |  |  | 181.3 | 181.6 |  |  | 181.6 |
| **Diluted EPS** | $**0.82** | $**0.10** |  | $**0.92** | $**0.62** | $**0.01** |  | $**0.63** |
| Year-over-year currency translation impact on current year diluted EPS | $(0.08) | $(0.01) |  | $(0.09) |  |  |  |  |
| **Diluted EPS at Constant Currency** | $**0.90** | $**0.11** |  | $**1.01** |  |  |  |  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 YTD 2022** | **Q4 YTD 2022** | **Q4 YTD 2022** | **Q4 YTD 2022** | **Q4 YTD 2021** | **Q4 YTD 2021** | **Q4 YTD 2021** | **Q4 YTD 2021** |
| | As Reported | Adjustments | | Adjusted | As Reported | Adjustments | | Adjusted |
| Total Revenue | 5522 |  |  | 5522 | 5195 |  |  | 5195 |
| Operating Income | 622 | 50 | a | 672 | 585 | 26 | a | 611 |
| Operating Margin | *11.3 %* |  |  | *12.2 %* | *11.3 %* |  |  | *11.8 %* |
| Interest Expense | (50) |  |  | (50) | (76) |  |  | (76) |
| Other Non-Operating Income (Expense) | 7 | 4 | b | 11 |  | 8 | b | 8 |
| U.K. Pension Buyout Settlement | (140) | 140 | b |  |  |  |  |  |
| Gain/(Loss) from sale of businesses | 1 | (1) |  |  | 2 | (2) |  |  |
| Income before Taxes | 440 | 193 |  | 633 | 511 | 32 |  | 543 |
| Provision for Income Taxes | (85) | (32) | c | (117) | (84) | (7) | c | (91) |
| Net Income attributable to Xylem | 355 | 161 |  | 516 | 427 | 25 |  | 452 |
| Diluted Shares | 181.0 |  |  | 181.0 | 181.5 |  |  | 181.5 |
| **Diluted EPS** | $**1.96** | $**0.89** |  | $**2.85** | $**2.35** | $**0.14** |  | $**2.49** |
| Year-over-year currency translation impact on current year diluted EPS | $(0.17) | $(0.17) |  | $(0.34) |  |  |  |  |
| **Diluted EPS at Constant Currency** | $**2.13** | $**1.06** |  | $**3.19** |  |  |  |  |

---

---

| | |
|:---|:---|
| a | Quarter-to-date: Restructuring & realignment costs of $16 million in 2022 and $6 million in 2021, as well as special charges of $1 million in 2022 (asset impairment charge) and $1 million in 2021 for UK pension plan charges. |
|  | Year-to-date: Restructuring & realignment costs of $34 million in 2022 and $22 million in 2021, as well as special charges of $16 million in 2022 ($2 million UK pension plan charges and $14 million of asset impairment charges) and $4 million ($1 million of intangible asset impairment charges and $3 million of other charges) in 2021. |
| b | Quarter-to-date: Special non-operating charges consist of $3 million in 2021 for costs related to the UK pension plan. |
|  | Year-to-date: Special non-operating charges consist of $144 million in 2022 related to the UK pension plan charges and buyout settlement and $8 million in 2021 for costs related to the UK pension plan. |
| c | Quarter-to-date: Net tax impact on restructuring & realignment costs of $3 million in 2022 and $1 million in 2021; net tax impact on special charges of $1 million in 2021; and $5 million in 2022 of a positive impact from tax related special charges and $6 million in 2021 of negative impact from tax related special benefits to GAAP tax, respectively. |
|  | Year-to-date: Net tax impact on restructuring & realignment costs of $7 million in 2022 and $5 million in 2021; $26 million net tax impact on special charges in 2022 and $2 million 2021; and $1 million of positive impact from tax related special charges to GAAP tax in 2022. |

---

------

Xylem Inc. Non-GAAP Reconciliation

Net Cash - Operating Activities vs. Free Cash Flow

($ Millions)

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Q1 | Q1 | Q2 | Q2 | Q3 | Q3 | Q4 | Q4 | Year Ended | Year Ended |
| | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 |
| **Net Cash - Operating Activities** | **$(81)** | $(26) | **$113** | $232 | **$202** | $112 | **$362** | $220 | **$596** | $**538** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital Expenditures - PP&E | (31) | (22) | (30) | (25) | (37) | (33) | (41) | (62) | (139) | (142) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital Expenditures - Software | (18) | (17) | (16) | (16) | (16) | (14) | (19) | (19) | (69) | (66) |
| **Capital Expenditures** | **(49)** | **(39)** | **(46)** | **(41)** | **(53)** | **(47)** | **(60)** | **(81)** | **(208)** | **(208)** |
| **Free Cash Flow** | **$(130)** | $(65) | **$67** | $191 | **$149** | $65 | **$302** | $139 | **$388** | $**330** |
| **Net Income** | **82** | 87 | **112** | 113 | **12** | 114 | **149** | 113 | **355** | **427** |
| Gain/(Loss) from sale of businesses | **1** |  | **—** | 2 | **—** |  | **—** |  | **1** | 2 |
| Impairment | **—** | (1) | **—** |  | **—** |  | **—** |  | **—** | (1) |
| U.K. pension buyout settlement - non-cash release from AOCI | **—** |  | **—** |  | **(140)** |  | **—** |  | **(140)** |  |
| U.K. pension buyout settlement - non-cash tax release from AOCI | **0** | 0 | **0** | 0 | **23** | 0 | **0** | 0 | **23** | 0 |
| Special Charges - non-cash impairment | **—** | (1) | **(1)** |  | **(12)** |  | **(1)** |  | **(14)** | (1) |
| **Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items** | **$81** | **$89** | **$113** | **$111** | **$141** | **$114** | **$150** | **$113** | **$485** | $**427** |
| **Operating Cash Flow Conversion** | **(99)%** | (30)% | **101%** | 205% | **1,683%** | 98% | **243%** | 195% | **168%** | **126%** |
| **Free Cash Flow Conversion** | **(160)%** | (73)% | **59%** | 172% | **106%** | 57% | **201%** | 123% | **80%** | **77%** |

---

------

Xylem Inc. Non-GAAP Reconciliation

EBITDA and Adjusted EBITDA by Quarter

($ Millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
|  | **Q1** | **Q2** | **Q3** | **Q4** | **Total** |
| Net Income | 82 | 112 | 12 | 149 | 355 |
| Net Income Margin | 6.4% | 8.2% | 0.9% | 9.9% | 6.4% |
| Depreciation | 28 | 28 | 27 | 28 | 111 |
| Amortization | 30 | 32 | 31 | 32 | 125 |
| Interest Expense (Income), net | 11 | 10 | 7 | 6 | 34 |
| Income Tax Expense | 16 | 24 | 5 | 40 | 85 |
| EBITDA | 167 | 206 | 82 | 255 | 710 |
| Share-based Compensation | 9 | 9 | 10 | 9 | 37 |
| Restructuring & Realignment | 4 | 8 | 6 | 16 | 34 |
| U.K. Pension Settlement |  |  | 140 |  | 140 |
| Special Charges | 2 | 3 | 14 | 1 | 20 |
| Loss/(Gain) from sale of business | (1) |  |  |  | (1) |
| Adjusted EBITDA | 181 | 226 | 252 | 281 | 940 |
| Revenue | 1272 | 1364 | 1380 | 1506 | 5522 |
| Adjusted EBITDA Margin | 14.2% | 16.6% | 18.3% | 18.7% | 17.0% |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
|  | **Q1** | **Q2** | **Q3** | **Q4** | **Total** |
| Net Income | 87 | 113 | 114 | 113 | 427 |
| Net Income Margin | 6.9% | 8.4% | 9.0% | 8.5% | 8.2% |
| Depreciation | 30 | 29 | 31 | 28 | 118 |
| Amortization | 32 | 33 | 31 | 31 | 127 |
| Interest Expense (Income), net | 19 | 19 | 20 | 11 | 69 |
| Income Tax Expense | 27 | 25 | 19 | 13 | 84 |
| EBITDA | 195 | 219 | 215 | 196 | 825 |
| Share-based Compensation | 9 | 8 | 8 | 8 | 33 |
| Restructuring & Realignment | 8 | 6 | 2 | 6 | 22 |
| Special Charges | 3 | 3 | 2 | 4 | 12 |
| Loss/(gain) from sale of business |  | (2) |  |  | (2) |
| Adjusted EBITDA | 215 | 234 | 227 | 214 | 890 |
| Revenue | 1256 | 1351 | 1265 | 1323 | 5195 |
| Adjusted EBITDA Margin | 17.1% | 17.3% | 17.9% | 16.2% | 17.1% |

---

------

Xylem Inc. Non-GAAP Reconciliation

EBITDA and Adjusted EBITDA by Quarter

Water Infrastructure

($ Millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
|  | Q1 | Q2 | Q3 | Q4 | Total |
| Operating Income | 74 | 108 | 104 | 132 | 418 |
| Depreciation | 11 | 11 | 11 | 11 | 44 |
| Amortization | 2 | 3 | 1 | 3 | 9 |
| Other non-operating expense, excluding interest income | (4) | 1 |  | (1) | (4) |
| EBITDA | 83 | 123 | 116 | 145 | 467 |
| Share-based Compensation | 1 |  |  | 1 | 2 |
| Restructuring & Realignment | 1 | 3 | 3 | 4 | 11 |
| Adjusted EBITDA | 85 | 126 | 119 | 150 | 480 |
| Revenue | 533 | 589 | 574 | 668 | 2364 |
| Adjusted EBITDA Margin | 15.9% | 21.4% | 20.7% | 22.5% | 20.3% |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
|  | Q1 | Q2 | Q3 | Q4 | Total |
| Operating Income | 71 | 93 | 101 | 122 | 387 |
| Depreciation | 11 | 11 | 11 | 10 | 43 |
| Amortization | 2 | 2 | 1 | 3 | 8 |
| Other non-operating expense, excluding interest | (2) | (2) | 1 | (2) | (5) |
| EBITDA | 82 | 104 | 114 | 133 | 433 |
| Share-based Compensation | 1 |  | 1 |  | 2 |
| Restructuring & Realignment | 5 | 4 | 1 | 2 | 12 |
| Adjusted EBITDA | 88 | 108 | 116 | 135 | 447 |
| Revenue | 509 | 569 | 547 | 622 | 2247 |
| Adjusted EBITDA Margin | 17.3% | 19.0% | 21.2% | 21.7% | 19.9% |

---

------

Xylem Inc. Non-GAAP Reconciliation

EBITDA and Adjusted EBITDA by Quarter

Applied Water

($ Millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
|  | Q1 | Q2 | Q3 | Q4 | Total |
| Operating Income | 59 | 61 | 77 | 61 | 258 |
| Depreciation | 5 | 4 | 4 | 4 | 17 |
| Amortization |  | 1 |  | 1 | 2 |
| Other non-operating expense, excluding interest income | (1) |  | (1) |  | (2) |
| EBITDA | 63 | 66 | 80 | 66 | 275 |
| Share-based Compensation | 1 | 1 | 2 |  | 4 |
| Restructuring & Realignment | 1 | 2 | 1 | 9 | 13 |
| Adjusted EBITDA | 65 | 69 | 83 | 75 | 292 |
| Revenue | 425 | 429 | 458 | 455 | 1767 |
| Adjusted EBITDA Margin | 15.3% | 16.1% | 18.1% | 16.5% | 16.5% |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
|  | Q1 | Q2 | Q3 | Q4 | Total |
| Operating Income | 66 | 64 | 60 | 50 | 240 |
| Loss/(Gain) from sale of business |  | 2 |  |  | 2 |
| Depreciation | 5 | 5 | 5 | 5 | 20 |
| Amortization | 1 | 1 |  |  | 2 |
| Other non-operating expense, excluding interest income |  | (1) |  | (2) | (3) |
| EBITDA | 72 | 71 | 65 | 53 | 261 |
| Share-based Compensation | 1 | 1 | 1 | 1 | 4 |
| Restructuring & Realignment | 1 | 2 | 2 | 2 | 7 |
| Loss/(Gain) from sale of business | 1 |  |  |  | 1 |
| Special Charges |  | (2) |  |  | (2) |
| Adjusted EBITDA | 75 | 72 | 68 | 56 | 271 |
| Revenue | 393 | 414 | 400 | 406 | 1613 |
| Adjusted EBITDA Margin | 19.1% | 17.4% | 17.0% | 13.8% | 16.8% |

---

------

Xylem Inc. Non-GAAP Reconciliation

EBITDA and Adjusted EBITDA by Quarter

Measurement & Control Solutions

($ Millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
|  | Q1 | Q2 | Q3 | Q4 | Total |
| Operating Income | (10) | (5) | (2) | 19 | 2 |
| Loss/(Gain) from sale of business | 1 |  |  |  | 1 |
| Depreciation | 9 | 8 | 8 | 8 | 33 |
| Amortization | 25 | 26 | 27 | 26 | 104 |
| Other non-operating expense, excluding interest income |  | (1) | (1) |  | (2) |
| EBITDA | 25 | 28 | 32 | 53 | 138 |
| Share-based Compensation | 1 | 2 | 2 | 1 | 6 |
| Restructuring & Realignment | 2 | 3 | 2 | 3 | 10 |
| Special Charges |  | 1 | 12 | 1 | 14 |
| Loss/(Gain) from sale of business | (1) |  |  |  | (1) |
| Adjusted EBITDA | 27 | 34 | 48 | 58 | 167 |
| Revenue | 314 | 346 | 348 | 383 | 1391 |
| Adjusted EBITDA Margin | 8.6% | 9.8% | 13.8% | 15.1% | 12.0% |
| **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
|  | Q1 | Q2 | Q3 | Q4 | Total |
| Operating Income | 9 | 13 | 7 | (17) | 12 |
| Loss/(Gain) from sale of business |  |  |  |  |  |
| Depreciation | 9 | 10 | 11 | 8 | 38 |
| Amortization | 27 | 27 | 27 | 26 | 107 |
| Other non-operating expense, excluding interest income | (1) | (1) |  |  | (2) |
| EBITDA | 44 | 49 | 45 | 17 | 155 |
| Share-based Compensation | 1 | 2 | 1 | 2 | 6 |
| Restructuring & Realignment | 2 |  | (1) | 2 | 3 |
| Adjusted EBITDA | 47 | 51 | 45 | 21 | 164 |
| Revenue | 354 | 368 | 318 | 295 | 1335 |
| Adjusted EBITDA Margin | 13.3% | 13.9% | 14.2% | 7.1% | 12.3% |

---

<br>